Drug Repurposing Global Market Report 2025

Description

Drug repurposing involves discovering new therapeutic applications for existing or previously unsuccessful drugs. This approach takes advantage of established safety data and pharmacological knowledge to shorten development timelines and reduce costs. The goal is to bring treatments to market more efficiently by skipping the initial stages of drug discovery.

The main approaches to drug repurposing include disease-centric, target-centric, and drug-centric strategies. Disease-centric repurposing involves focusing on a particular disease and evaluating a range of existing drugs to determine their potential efficacy, regardless of their original intended target. The drug types commonly involved are biologics and small molecules. Therapeutic areas include oncology, neurology, infectious diseases, cardiovascular conditions, and autoimmune disorders, with administration routes such as oral, intravenous, topical, inhalation, and intramuscular. These efforts serve various end users, including pharmaceutical companies, academic and research institutions, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The drug repurposing market research report is one of a series of new reports from The Business Research Company that provides drug repurposing market statistics, including drug repurposing industry global market size, regional shares, competitors with a drug repurposing market share, drug repurposing market segments, market trends and opportunities, and any further data you may need to thrive in the drug repurposing industry. This drug repurposing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug repurposing market size has grown strongly in recent years. It will grow from $34.12 billion in 2024 to $37.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the escalating costs of developing new drugs, a growing number of drug failures in clinical trials, increased demand for quicker drug approvals, greater availability of off-patent medications, and rising levels of government and academic research funding.

The drug repurposing market size is expected to see strong growth in the next few years. It will grow to $53.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be credited to the rising demand for cost-effective therapies, increased investments by pharmaceutical companies, growing partnerships among biotech firms, and the broadening scope of applications in oncology and neurology. Key trends anticipated during the forecast period include progress in computational drug discovery tools, enhanced utilization of artificial intelligence and machine learning in drug repurposing, innovations in predictive modeling for assessing drug efficacy, the integration of big data analytics into drug screening processes, and advancements in the identification of biomarkers.

The increasing prevalence of neurodegenerative diseases is expected to drive the growth of the drug repurposing market in the future. Neurodegenerative diseases are a group of disorders marked by the progressive loss of neuron structure or function, including neuronal death. The rise in conditions such as Alzheimer's dementia is largely due to increased life expectancy, as aging remains the primary risk factor contributing to the gradual decline of neuronal function over time. Drug repurposing aids in treating neurodegenerative diseases by identifying existing drugs with established safety profiles that can be redirected to target relevant disease pathways, thereby speeding up the development of effective therapies. For example, in March 2023, the Alzheimer's Association, a US-based nonprofit voluntary health organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, with projections estimating an increase to 13.8 million by 2060. Consequently, the rising prevalence of neurodegenerative diseases is fueling the expansion of the drug repurposing market.

Key companies in the drug repurposing market are investing in cutting-edge technologies such as artificial intelligence (AI)-powered drug-protein interaction modeling to hasten the discovery of new therapeutic applications for existing drugs. AI-powered drug-protein interaction modeling uses artificial intelligence and machine learning to predict how drugs interact with proteins across the human proteome, leveraging extensive datasets to improve accuracy and confidence. For instance, in July 2025, Cosmos Health Inc., a US-based healthcare company, launched Cloudscreen 2.0, an advanced AI platform designed for drug repurposing. This next-generation system processes datasets over 100 times larger than before, enabling comprehensive analysis of drug-protein interactions. By integrating mutagenesis data and tools to analyze disordered proteins, the platform targets diseases including cancer, obesity, and diabetes. Furthermore, GPU-based cloud computing supports scalable processing, making the platform a significant innovation for accelerating research and development pipelines across multiple therapeutic areas.

In July 2025, Predictive Oncology Inc., a US-based company specializing in AI-driven drug discovery and repurposing, partnered with YA II PN, Ltd., securing a $10 million share purchase agreement. Through this collaboration, Predictive Oncology aims to enhance its AI-driven platform to speed up the identification of new therapeutic uses for existing drugs and optimize oncology drug discovery processes. YA II PN, Ltd. is a US-based investment fund managed by Yorkville Advisors Global, LP, which provides financing to support such initiatives.

Major players in the drug repurposing market are F. Hoffmann-La Roche Ltd, International Business Machines Corporation (IBM), Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co. Ltd., Celltrion Inc., Alnylam Pharmaceuticals Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Cosmos Health Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., and BioXcel Therapeutics Inc.

North America was the largest region in the drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug repurposing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug repurposing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug repurposing market consists of revenues earned by entities by providing services such as computational drug screening, clinical trial design and support, regulatory consulting, bioinformatics analysis, and data mining of existing drug databases. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug repurposing market also includes sales of thalidomide, sildenafil, minoxidil, metformin, and azithromycin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Repurposing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug repurposing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug repurposing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug repurposing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Disease-Centric; Target-Centric; Drug-Centric
2) By Drug Molecules: Biologics; Small Molecule
3) By Therapeutic Area: Oncology; Neurology; Infectious Diseases; Cardiovascular Diseases; Autoimmune Disorders
4) By Route Of Administration: Oral; Intravenous; Topical; Inhalation; Intramuscular
5) By End-User: Pharmaceutical Companies; Research And Academic Institutes; Contract Research Organizations
Subsegments:
1) By Disease-Centric: Phenotypic Screening; Epidemiological Analysis; Clinical Observation-Based Repurposing
2) By Target-Centric: Protein Target Modulation; Pathway Modulation; Biomarker-Based Targeting
3) By Drug-Centric: Off-Target Activity Identification; Structure-Based Drug Repositioning; Adverse Effect-Based Repurposing
Companies Mentioned: F. Hoffmann-La Roche Ltd ; International Business Machines Corporation (IBM); Bayer AG; Takeda Pharmaceutical Company Limited; Amgen Inc.; Teva Pharmaceutical Industries Limited; Astellas Pharma Inc.; UCB S.A.; Eisai Co Ltd.; Celltrion Inc.; Alnylam Pharmaceuticals Inc.; Evotec SE; BenevolentAI Limited; Insilico Medicine Inc.; Cosmos Health Inc.; Recursion Pharmaceuticals Inc.; Pharnext S.A.; Healx Ltd.; Algernon Pharmaceuticals Inc.; BioXcel Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r36987

1. Executive Summary

2. Drug Repurposing Market Characteristics

3. Drug Repurposing Market Trends And Strategies

4. Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Drug Repurposing Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Repurposing Market Growth Rate Analysis
5.4. Global Drug Repurposing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Repurposing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Repurposing Total Addressable Market (TAM)

6. Drug Repurposing Market Segmentation

6.1. Global Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disease-Centric
Target-Centric
Drug-Centric
6.2. Global Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Small Molecule
6.3. Global Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Infectious Diseases
Cardiovascular Diseases
Autoimmune Disorders
6.4. Global Drug Repurposing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Topical
Inhalation
Intramuscular
6.5. Global Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Research And Academic Institutes
Contract Research Organizations
6.6. Global Drug Repurposing Market, Sub-Segmentation Of Disease-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phenotypic Screening
Epidemiological Analysis
Clinical Observation-Based Repurposing
6.7. Global Drug Repurposing Market, Sub-Segmentation Of Target-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Target Modulation
Pathway Modulation
Biomarker-Based Targeting
6.8. Global Drug Repurposing Market, Sub-Segmentation Of Drug-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Off-Target Activity Identification
Structure-Based Drug Repositioning
Adverse Effect-Based Repurposing

7. Drug Repurposing Market Regional And Country Analysis

7.1. Global Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Repurposing Market

8.1. Asia-Pacific Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Repurposing Market

9.1. China Drug Repurposing Market Overview
9.2. China Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Repurposing Market

10.1. India Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Repurposing Market

11.1. Japan Drug Repurposing Market Overview
11.2. Japan Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Repurposing Market

12.1. Australia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Repurposing Market

13.1. Indonesia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Repurposing Market

14.1. South Korea Drug Repurposing Market Overview
14.2. South Korea Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Repurposing Market

15.1. Western Europe Drug Repurposing Market Overview
15.2. Western Europe Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Repurposing Market

16.1. UK Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Repurposing Market

17.1. Germany Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Repurposing Market

18.1. France Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Repurposing Market

19.1. Italy Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Repurposing Market

20.1. Spain Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Repurposing Market

21.1. Eastern Europe Drug Repurposing Market Overview
21.2. Eastern Europe Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Repurposing Market

22.1. Russia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Repurposing Market

23.1. North America Drug Repurposing Market Overview
23.2. North America Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Repurposing Market

24.1. USA Drug Repurposing Market Overview
24.2. USA Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Repurposing Market

25.1. Canada Drug Repurposing Market Overview
25.2. Canada Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Repurposing Market

26.1. South America Drug Repurposing Market Overview
26.2. South America Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Repurposing Market

27.1. Brazil Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Repurposing Market

28.1. Middle East Drug Repurposing Market Overview
28.2. Middle East Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Repurposing Market

29.1. Africa Drug Repurposing Market Overview
29.2. Africa Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Repurposing Market Competitive Landscape And Company Profiles

30.1. Drug Repurposing Market Competitive Landscape
30.2. Drug Repurposing Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Repurposing Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Limited
31.2. Astellas Pharma Inc.
31.3. UCB S.A.
31.4. Eisai Co Ltd.
31.5. Celltrion Inc.
31.6. Alnylam Pharmaceuticals Inc.
31.7. Evotec SE
31.8. BenevolentAI Limited
31.9. Insilico Medicine Inc.
31.10. Cosmos Health Inc.
31.11. Recursion Pharmaceuticals Inc.
31.12. Pharnext S.A.
31.13. Healx Ltd.
31.14. Algernon Pharmaceuticals Inc.
31.15. BioXcel Therapeutics Inc.

32. Global Drug Repurposing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Repurposing Market

34. Recent Developments In The Drug Repurposing Market

35. Drug Repurposing Market High Potential Countries, Segments and Strategies

35.1 Drug Repurposing Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Repurposing Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Repurposing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer